Heron Therapeutics Inc HRTX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/22 EDT
3.85quote price arrow up+0.06 (+1.58%)
Volume
19,275,065
Close
3.79quote price arrow down-0.05 (-1.39%)
52 week range
3.12 - 16.63
Loading...
  • Open3.67
  • Day High3.79
  • Day Low3.57
  • Prev Close3.54
  • 52 Week High16.63
  • 52 Week High Date06/25/21
  • 52 Week Low3.12
  • 52 Week Low Date05/10/22

Key Stats

  • Market Cap388.40M
  • Shares Out102.48M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.41
  • YTD % Change-58.49

KEY STATS

  • Open3.67
  • Day High3.79
  • Day Low3.57
  • Prev Close3.54
  • 52 Week High16.63
  • 52 Week High Date06/25/21
  • 52 Week Low3.12
  • 52 Week Low Date05/10/22
  • Market Cap388.40M
  • Shares Out102.48M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.41
  • YTD % Change-58.49

RATIOS/PROFITABILITY

  • EPS (TTM)-2.30
  • P/E (TTM)-1.65
  • Fwd P/E (NTM)-2.07
  • EBITDA (TTM)-225.634M
  • ROE (TTM)-210.69%
  • Revenue (TTM)89.79M
  • Gross Margin (TTM)46.35%
  • Net Margin (TTM)-258.35%
  • Debt To Equity (MRQ)622.47%

EVENTS

  • Earnings Date08/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Heron Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Heron Therapeutics, Inc. is a commercial-stage biotechnology company. The Company commercializes a portfolio of products to care for acute care and oncology patients. Its oncology care product portfolio includes SUSTOL and CINVANTI. SUSTOL is used for the prevention of acute and delayed nausea and vomiting associated with both moderately emetogenic chemotherapy (MEC), and anthracycline and cyclophosphamide (AC) combination chemotherapy regimens. CINVANTI is an intravenous...
Barry Quart Pharm.D.
Chairman of the Board, Chief Executive Officer
John Poyhonen
President, Chief Commercial Officer
David Szekeres J.D.
Chief Operating Officer, Executive Vice President
Lisa Peraza CPA
Chief Accounting Officer, Vice President
Kimberly Manhard
Executive Vice President - Drug Development, Director
John Arthur Ph.D.
Vice President - Manufacturing and Supply
Address
4242 Campus Point Ct Ste 200
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
ADMA
ADMA Biologics Inc
2.02UNCHUNCH
RIGL
Rigel Pharmaceuticals Inc
2.21UNCHUNCH
PGEN
Precigen Inc
1.28UNCHUNCH
CCCC
C4 Therapeutics Inc
6.87UNCHUNCH
TKNO
Alpha Teknova Inc
10.63UNCHUNCH